While there is no evidence that semaglutide causes thyroid nodules to grow or become malignant in humans, baseline thyroid imaging and periodic monitoring may be recommended for patients with known nodular disease
While these indirect findings are valuable in understanding the broader implications of semaglutide on hormonal regulation, they do not offer conclusive evidence regarding the medications specific impact on the menstrual cycle
Now, heated tobacco products (HTPs) offer a similar experience to combustible cigarettes, but can
A team of students at Trinity College, University of Cambridge, has investigated the impact of stopping the medication, modelling the trajectory of weight regain over 12 months and beyond
Semaglutide is categorized as a glucagon-like peptide-1 receptor agonist (GLP-1 RAs)
Jastreboff AM et al., SURMOUNT-1, NEJM 2022 (NEJMoa2206038) : tirzepatide up to 15 mg, loss -22,5% at 72 weeks